JPRN-UMIN000027283
Recruiting
Phase 1
The safety trial of sonodynamic therapy for unresectable intractable cancer - Sonodynamic therapy for unresectable intractable cancer
Conditionsunresectable intractable cancer
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- unresectable intractable cancer
- Sponsor
- Tokyo Medical University
- Enrollment
- 15
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.The patients who has cancer of other organs or is suspected 2\.The treatment history of radiotherapy 3\.The treatment history of chemotherapy before registration within one month 4\.The treatment history of HIFU therapy before registration within two months 5\.The patients by whom heomostatic troubles, such as an antiplatelet therapy and an anticoagulation, are expected 6\.The patients who has invasion of cancer to stomach and duodenum 7\.The patients who has obstructive jaundice (the patients after removing of obstruction is available) 8\.The patients by whom tumor adjoins the vena cava inferior and tumor emboli exist in a vena cava inferior (however, good, if the site is avoided) 9\.The patients by whom tumor adjoins aorta and a calcified lesion is an exist (however, good, if the site is avoided) to aorta 10\.The patients who has cystic lesion in pancreatic cancer 11\.The patients of the use history of anthracycline drug 12\.The patients who has an anamnestic of a critical drug hypersensitivity 13\.The patients who has a radiocontrast\-agent allergy 14\.The patients who has a critical encephalopathy and pulmonary disease (pneumonitis, pulmonary fibrosis which can be checked on an imaging) 15\.The patients who has an anamnestic of congestive heart failure, a symptomatic coronary artery disease, an irregularity of pulse with poor control with medicament, myocardial infarction for less than six months, or unstable angina 16\.The patients who has an active infective disease which needs a systemic treatment 17\.Pregnant women or the patients who may have become pregnant, and the out\-of patient of a contraceptive intention 18\.The patients who judged that principal investigator was unsuitable as subject
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The effect of Sound Therapy on Pain severity after cesarean sectioScores Pain after Sound Therapy.Severe abdominal painIRCT2015020114049N2Vice chancellor for research, Jahrom University of Medical Sciences57
Recruiting
N/A
Evaluation of ultrasound therapy in myofascial paiHealth Condition 1: M638- Disorders of muscle in diseases classified elsewhereCTRI/2021/12/038757valluri harini venkata padmanjali
Recruiting
N/A
the Influence of sound therapy on signs variations of hemodynamic in upper-body orthopedic patients during general anesthesiaIRCT2017051414049N5Vice chancellor for research, Jahrom University of Medical Sciences72
Recruiting
Phase 2
The effect of ultrasound guidance on local analgesic blockInjury of nerves at ankle.Injury of nerves at ankle and foot levelIRCT2017041733477N1Vice Chancellor for Research, Mashhad University of Medical Sciences80
Recruiting
N/A
A randomized clinical trial of ultrasound-guided double percutaneous needling versus high-energy extracorporeal shockwave therapy in the treatment of calcific tendinopathy of the rotator cuff.calcific tendinopathyshoulder pain10043237NL-OMON40188Spaarne Ziekenhuis100